Journal
MOVEMENT DISORDERS
Volume 22, Issue 5, Pages 720-722Publisher
WILEY
DOI: 10.1002/mds.21273
Keywords
malignant melanoma; Parkinson's disease; levodopa
Categories
Funding
- NINDS NIH HHS [NS24778] Funding Source: Medline
Ask authors/readers for more resources
The available epidemiological data on the incidence of malignant melanoma in Parkinson's disease are contradictory. The role of levodopa therapy in this context has been debated. We identified all known cases of malignant melanoma (N = 5) in the DATATOP clinical trial cohort and compared that to published expected values (N = 1.5) for a standard healthy population. The standardized event ratio was 3.3 (95% confidence interval, 1.1-7.8), indicating that incidence of malignant melanoma was higher than expected. We found no association between levodopa therapy and the incidence of melanoma. (c) 2007 Movement Disorder Society.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available